The FGFR1 Gene Jackson-Weiss Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the FGFR1 gene that are associated with Jackson-Weiss Syndrome. This condition is a rare genetic disorder characterized by craniosynostosis, which involves the premature fusion of skull bones, leading to an abnormal head shape, and can also affect the shape of the feet and hands, among other symptoms. Early detection through genetic testing is crucial for managing the condition and planning appropriate treatments.
DNA Labs UAE provides this comprehensive test at a cost of 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the FGFR1 gene that are indicative of Jackson-Weiss Syndrome. The results from this test can help guide clinical decisions, including surgical interventions to correct bone abnormalities and therapies to support developmental outcomes. It is an invaluable tool for families with a history of the syndrome or for individuals showing symptoms, offering a pathway to a clearer diagnosis and tailored care plan.
The FGFR2 Gene Jackson-Weiss Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the FGFR2 gene, which are known to cause Jackson-Weiss Syndrome. This condition is a rare genetic disorder characterized by abnormalities in the development of the skull, facial features, and, occasionally, the feet. Early detection through this genetic test can play a crucial role in managing and treating the syndrome effectively.
DNA Labs UAE, a leading facility in genetic testing, offers this comprehensive test at a cost of 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of specific mutations in the FGFR2 gene. Results from this test can provide valuable information for affected individuals and their families regarding the diagnosis, prognosis, and potential treatment options for Jackson-Weiss Syndrome, thereby facilitating informed medical and personal decisions.
The RBBP8 Gene Jawad Syndrome Genetic Test is a specialized diagnostic tool used to identify mutations in the RBBP8 gene, which are linked to Jawad Syndrome. This condition is a rare genetic disorder characterized by various developmental anomalies including craniofacial abnormalities, growth delays, and potentially other systemic involvements. The test is crucial for confirming the diagnosis, allowing for appropriate management and counseling for affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs advanced genetic sequencing technologies to accurately analyze the RBBP8 gene for any mutations that are known to cause Jawad Syndrome. Given the complexity and precision of the test, it is priced at 4400 AED. This cost reflects the comprehensive nature of the analysis, ensuring a reliable diagnosis that can guide treatment options and support familial genetic counseling. It's important for potential clients to consult with healthcare professionals to understand the implications of the test results fully.
The "KMT2D Gene Kabuki Syndrome Type 1 Genetic Test" is a specialized diagnostic procedure aimed at detecting mutations in the KMT2D gene, which are primarily responsible for Kabuki Syndrome Type 1. This genetic condition is characterized by distinctive facial features, growth delays, intellectual disability, and a variety of other health issues. The test is crucial for accurate diagnosis and management of the syndrome, allowing for tailored treatments and interventions to improve the quality of life of affected individuals.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, this test involves analyzing the patient's DNA to identify any alterations in the KMT2D gene. The process is comprehensive, ensuring high accuracy and reliability in the results.
The cost of the KMT2D Gene Kabuki Syndrome Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, as it opens the door to specialized care and support for individuals with Kabuki Syndrome. Families and healthcare providers seeking to confirm a diagnosis of Kabuki Syndrome Type 1 can rely on this test for its precision and the expertise of the lab conducting the analysis.
The KDM6A Gene Kabuki Syndrome Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the KDM6A gene, which are associated with Kabuki Syndrome Type 2. Kabuki syndrome is a rare, congenital disorder characterized by distinctive facial features, growth delays, intellectual disability, and various organ malformations. The test involves analyzing the patient's DNA to detect any abnormalities or mutations in the KDM6A gene that could indicate the presence of the syndrome. This genetic testing is crucial for early diagnosis, which can significantly aid in the management and treatment of the condition. The cost of the test is 4400 AED, making it an accessible option for those seeking comprehensive genetic analysis in the UAE. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic health, leading to better-informed healthcare decisions.
Paternal Uniparental Disomy (UPD) of Chromosome 14, also known as Kagami-Ogata Syndrome, is a rare genetic condition that occurs when a child inherits two copies of chromosome 14 from their father, instead of one copy from each parent. This results in a range of developmental issues and physical abnormalities, including distinctive facial features, skeletal anomalies, and growth retardation.
The genetic test for Kagami-Ogata Syndrome involves analyzing the patient's DNA to detect the presence of paternal UPD on chromosome 14. This test is crucial for the accurate diagnosis and management of the syndrome, allowing for early intervention and support for affected individuals and their families.
In the UAE, this specialized genetic test can be conducted at DNA Labs UAE, a leading facility in genetic diagnostics. The cost of the test is 4400 AED, which covers the comprehensive analysis required to detect this specific uniparental disomy. Given the complexity and rarity of Kagami-Ogata Syndrome, accessing this test can provide essential insights for affected families, guiding treatment and support options.
The FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the FGFR1 gene, which are associated with Kallmann Syndrome Type 2. Kallmann Syndrome is a genetic condition characterized by the combination of delayed or absent puberty and an impaired sense of smell (anosmia). The FGFR1 gene plays a critical role in the development of the olfactory system and certain hormonal axes responsible for sexual development. Mutations in this gene can disrupt these processes, leading to the symptoms observed in Kallmann Syndrome.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed in the laboratory to detect any genetic variations in the FGFR1 gene that are known to contribute to the condition. This genetic testing is crucial for the accurate diagnosis of Kallmann Syndrome Type 2, enabling healthcare providers to offer appropriate treatment and counseling for affected individuals and their families. DNA Labs UAE employs state-of-the-art genetic testing technologies to ensure high accuracy and reliability of the test results.
The PROK2 Gene Kallmann Syndrome Type 4 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PROK2 gene, which are linked to the development of Kallmann Syndrome Type 4. This rare genetic disorder is characterized by a combination of delayed or absent puberty and an impaired sense of smell (anosmia) or a reduced sense of smell (hyposmia). The condition is part of a group of syndromes that affect the production of hormones responsible for sexual development.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. By examining the patient's DNA, the test aims to detect specific mutations in the PROK2 gene that are known to cause Kallmann Syndrome Type 4. This information is crucial for confirming a diagnosis, which can then guide treatment options and genetic counseling for affected individuals and their families.
The cost of the PROK2 Gene Kallmann Syndrome Type 4 Genetic Test is 4400 AED. While the price may seem high, the test offers valuable insights into the genetic basis of the condition, enabling targeted interventions and support for those affected by this syndrome.
The CHD7 gene Kallmann Syndrome Type 5 genetic test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CHD7 gene, which are linked to the development of Kallmann Syndrome Type 5. This condition is a form of congenital hypogonadotropic hypogonadism, characterized by a lack of sense of smell (anosmia) and delayed or absent puberty, among other possible features such as hearing loss and renal anomalies. The test is critical for individuals showing symptoms of the syndrome or those with a family history of the condition, as it provides essential information for accurate diagnosis and management.
The testing process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect mutations in the CHD7 gene. A positive result indicates a mutation in the CHD7 gene that is known to cause Kallmann Syndrome Type 5, while a negative result can help rule out this specific genetic cause of the patient's symptoms.
The cost of the CHD7 gene Kallmann Syndrome Type 5 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the genetic mutation, providing a crucial step towards a proper diagnosis and the development of an appropriate treatment plan for affected individuals. Given the specialized nature of this test and its significance in the management of Kallmann Syndrome Type 5, it represents a valuable tool in the field of genetic diagnostics.
The ANKRD11 Gene KBG Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the ANKRD11 gene, which are associated with KBG syndrome. KBG syndrome is a rare genetic disorder characterized by distinctive facial features, developmental delays, short stature, and skeletal abnormalities, among other symptoms. The test involves analyzing the patient's DNA to identify any anomalies in the ANKRD11 gene, which plays a crucial role in development and function of various body systems.
Priced at 4400 AED, this test is a critical tool for healthcare professionals and families seeking a definitive diagnosis of KBG syndrome. Early detection through the ANKRD11 Gene KBG Syndrome Genetic Test can facilitate timely intervention and management of the condition, improving the quality of life for affected individuals. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing results, making it a trusted choice for genetic testing services in the region.
